Pharmaceutical, biotechnology and medical products companies
October 19, 2016

Accenture Named a Leader in Worldwide Life Sciences Manufacturing and Supply Chain Digital Transformation, According to IDC MarketScape

NEW YORK; Oct. 19, 2016 – Accenture has been positioned as a Leader in the inaugural “IDC MarketScape: Worldwide Life Science Manufacturing and Supply Chain Digital Transformation Vendor Assessment” (doc #US40510516, September 2016) report.
September 15, 2016

Accenture Launches HealthTech Innovation Challenge to Foster Technology Innovation In the Healthcare Industry

NEW YORK; Sept. 15, 2016 –- Accenture today announced the creation of the Accenture HealthTech Innovation Challenge which brings together leading-edge startups with prominent life sciences and health companies to tackle some of the world’s greatest health challenges including access, affordability and transparency.
July 20, 2016

Accenture Named a Leader in Worldwide Life Sciences Sales and Marketing Digital Transformation, According to IDC MarketScape

NEW YORK; July 20, 2016 – Accenture has been positioned as a Leader in the inaugural “IDC MarketScape Worldwide Life Science Sales and Marketing Digital Transformation Vendor Assessment” (doc #US40510716, July 2016) report. 
June 29, 2016

Accenture Selected to Help Stryker Improve Operating Efficiencies

NEW YORK; June 29, 2016 – Accenture (NYSE: ACN) has been selected by Stryker, a leading medical technology company, to support the standardization of its business processes across the company.
June 13, 2016

Sagacious Consultants Is Highest Rated Firm for Revenue-Cycle Optimization in Latest KLAS Report

LENEXA, Kansas; June 13, 2016 – Sagacious Consultants, now part of Accenture (NYSE: ACN), is tied as the highest-rated firm for Revenue Cycle Redesign and Optimization in KLAS’ 2016 Healthcare IT Advisory report. Sagacious’ consulting services help providers optimize their revenue cycle operations and technologies they use to improve financial performance.
June 03, 2016

Accenture Wins Covenant House Washington DC Dove Award

WASHINGTON D.C; June 3, 2016 – Accenture (NYSE: ACN) has received the Covenant House Washington 2016 Dove Award for its work helping to create a brighter future for some of the District’s most vulnerable young people. The award was presented last night at Covenant House’s annual Night of the Stars Gala. 
May 25, 2016

New Research from Accenture Reveals Gap in Pharma R&D’s Journey to Delivering Better Patient Outcomes

NEW YORK; May 25, 2016 – Despite R&D-focused pharmaceutical executives recognizing digital as the primary driver to be more patient-outcome focused, only half of them are currently adopting digital, according to a new report from Accenture.
May 19, 2016

Accenture Collaborates with Salesforce to Extend Capabilities of Salesforce Health Cloud, Provides Life Sciences Companies and Healthcare Providers with an Integrated Solution to Improve Patient Support

NEW YORK; May 19, 2016 – Accenture has collaborated with Salesforce to extend the capabilities of Salesforce Health Cloud, giving life sciences companies and healthcare providers the ability to support more informed patient decisions, help increase patient engagement across their caregiver networks, and more efficiently and effectively manage patient data.
April 12, 2016

Pharmaceutical Companies to Accelerate Investment in Patient-Centric Capabilities and Services Over Next Two Years, According to Accenture Report

NEW YORK; April 12, 2016 – The vast majority of large pharmaceutical companies plan to increase their investment in patient-centric capabilities such as treatment adherence programs, remote patient monitoring and medication delivery and support over the next two years, according to a new report from Accenture.
April 11, 2016

Accenture Positioned as a Leader in an IDC MarketScape: Worldwide Life Sciences Research & Development Vendor Assessment on Strategic Consulting

NEW YORK; April 11, 2016 – Accenture is positioned as a Leader in an IDC Health Insights MarketScape vendor assessment covering strategic consulting across the life sciences research and development (R&D) industry. This is the second consecutive time Accenture has achieved this position.